TY  - JOUR
AU  - Loricera, Javier
AU  - Castañeda, Santos
AU  - Moriano, Clara
AU  - Narváez, Javier
AU  - Aldasoro, Vicente
AU  - Maiz, Olga
AU  - Melero, Rafael
AU  - Villa, Ignacio
AU  - Vela, Paloma
AU  - Romero-Yuste, Susana
AU  - Callejas, José L
AU  - de Miguel, Eugenio
AU  - Galíndez-Agirregoikoa, Eva
AU  - Sivera, Francisca
AU  - Fernández-López, Jesús C
AU  - Galisteo, Carles
AU  - Ferraz-Amaro, Iván
AU  - Sánchez-Martín, Julio
AU  - Sánchez-Bilbao, Lara
AU  - Calderón-Goercke, Mónica
AU  - Casado, Alfonso
AU  - Hernández, José L
AU  - González-Gay, Miguel A
AU  - Blanco, Ricardo
PY  - 2022
DO  - 10.1177/1759720X221113747
SN  - 1759-720X
UR  - http://hdl.handle.net/10668/20213
T2  - Therapeutic advances in musculoskeletal disease
AB  - Visual involvement is the most feared complication of giant cell arteritis (GCA). Information on the efficacy of tocilizumab (TCZ) for this complication is scarce and controversial. We assessed a wide series of GCA treated with TCZ, to evaluate its...
LA  - en
KW  - giant cell arteritis
KW  - large-vessel vasculitis
KW  - tocilizumab
KW  - visual involvement
TI  - Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients.
TY  - research article
VL  - 14
ER  -